Akèy › Timè nan sèvo › Virginia › Arlington
Etid klinik pou Timè nan sèvo nan Arlington, VA
8 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Inova Schar Cancer Institute, Fairfax · 11 mi lwen
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
- NEXT Virginia, Fairfax · 11 mi lwen
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi lwen
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Ap rekriteFaz 2
- Inova Center for Personalized Health, Fairfax · 11 mi lwen
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Ap rekriteFaz 1
- Next Oncology -Virginia, Fairfax · 11 mi lwen
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Ap rekriteEtid obsèvasyon
- INOVA Health, Fairfax · 11 mi lwen
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- NEXT Virginia, Fairfax · 11 mi lwen
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Ap rekriteFaz 1/2
- NEXT Virginia, Fairfax · 11 mi lwen
Etid Timè nan sèvo nan lòt vil
- Houston, TX35 etid
- Boston, MA28 etid
- New York City, NY25 etid
- Washington, DC20 etid
- Los Angeles, CA16 etid
- Miami, FL15 etid
- Durham, NC14 etid
- St. Louis, MO12 etid
- Cleveland, OH11 etid
- Seattle, WA11 etid
- Rochester, MN11 etid
- Baltimore, MD11 etid
Lòt etid nan Arlington
- Kansè Poumon ki pa ti selil104 etid
- Kansè Metastatik53 etid
- Kansè kolorektal52 etid
- Kansè (tout kalite)48 etid
- Kansè nan tete46 etid
- Kansè ovè46 etid
- Kansè poumon41 etid
- Kansè Endomèt39 etid
- Kansè pankreyas33 etid
- Karsinòm selil skuamèz tèt ak kou26 etid
- Kansè poumon selil ti23 etid
- Kansè tete negatif triple20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.